&noscript=1 />

Alzheimer’s Disease Research Program

David Irwin, MD

Alzheimer's disease is the sixth leading cause of death in the United States. An irreversible degeneration of the brain that causes disruptions in memory, cognition, personality, and other functions, it eventually leads to death from complete brain failure.

More than five million Americans ages 65 and older are thought to have Alzheimer's disease. By 2050, that figure may increase to more than 14 million.

Everything you need to manage Alzheimer's disease

Program History

Since 1985, the Alzheimer's Disease Research (ADR) program has awarded nearly $140 million to support promising research in fields ranging from molecular biology to genetics to epidemiology. ADR is currently supporting 152 outstanding biomedical researcher projects.

Download the ADR Grants Yearbooks in PDF format and view our grantees:

Research We Have Funded

A few examples:

Learn more about the research we currently fund and the research we have funded over the years. 

Important Breakthroughs

Well-designed research pays off. Recent BrightFocus-sponsored findings in Alzheimer's disease have indicated that:

With further research, each of these discoveries may contribute to the development of new treatments and preventions.


Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.